Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

U.S. FDA formally approves the Gilead Sciences drug Remdesivir, commonly known as Veklury, for young children with COVID-19

The U.S. FDA formally approves the Gilead Sciences drug Remdesivir, commonly known as Veklury, for young children with COVID-19.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthU.S. FDA formally approves the Gilead Sciences drug Remdesivir, commonly known as Veklury, for young children with COVID-19

The U.S. FDA formally approves the Gilead Sciences drug Remdesivir, commonly known as Veklury, for young children with COVID-19.

View Premium plansBrowse free archive reports